TickerFactsScreenerDevelopers

PDS Biotechnology Corp (PDSB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$21.75M2016: -$32.19M2017: -$40.70M2018: -$1.57M2019: -$18.07M2020: -$13.15M2021: -$12.49M2022: -$25.71M2023: -$33.64M2024: -$35.03M2025: -$27.75M-$27.75M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$27.75M+20.8%
2024-$35.03M-4.1%
2023-$33.64M-30.8%
2022-$25.71M-105.9%
2021-$12.49M+5.0%
2020-$13.15M+27.2%
2019-$18.07M-1051.5%
2018-$1.57M+96.1%
2017-$40.70M-26.4%
2016-$32.19M-48.0%
2015-$21.75M—